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Abstract
Background: Modeling in systems biology is vital for understanding the complexity of biological systems across
scales and predicting system-level behaviors. To obtain high-quality pathway databases, it is essential to improve
the efficiency of model validation and model update based on appropriate feedback.
Results: We have developed a new method to guide creating novel high-quality biological pathways, using a rule-
based validation. Rules are defined to correct models against biological semantics and improve models for
dynamic simulation. In this work, we have defined 40 rules which constrain event-specific participants and the
related features and adding missing processes based on biological events. This approach is applied to data in Cell
System Ontology which is a comprehensive ontology that represents complex biological pathways with dynamics
and visualization. The experimental results show that the relatively simple rules can efficiently detect errors made
during curation, such as misassignment and misuse of ontology concepts and terms in curated models.
Conclusions: A new rule-based approach has been developed to facilitate model validation and model
complementation. Our rule-based validation embedding biological semantics enables us to provide high-quality
curated biological pathways. This approach can serve as a preprocessing step for model integration, exchange and
extraction data, and simulation.
Background
Modeling in systems biology is vital for the system-level
understanding of biological processes and predicting the
behavior of the system at each level. To obtain high-
quality pathway databases, many important databases
are built by manual curation sometimes with the aid of
computer. A typical curation process is well illustrated
in [1]. First, biological information resources are col-
lected from literature, background knowledge, and other
databases.
To create and evaluate pathway models, the informa-
tion is organized into the building blocks in pathway
databases. After creating the pathways models, the
domain experts validate the created pathways and the
curators update them based on appropriate feedback.
This validation and update are an iterative procedure to
obtain the desired specific annotated pathway.
Biological pathways are abstract representation of
experimental data. Ontology-based representations for
biological pathways have emerged because such formats
provide the advantages of defining and constraining
d i v e r s ed a t a[ 2 , 3 ] .T h ep a t h w a yf o r m a ti sg i v e ni ns o m e
representational language, while the generation of
instance data is usually separated from ontology develop-
ment. Although for the appropriate use of an ontology,
formal definitions and informal documentation are given,
it is sometimes difficult to avoid misassignment and mis-
use of ontology concepts. In the hierarchical structure of
the ontology format, a more specific subclass should be
selected instead of an upper class, such that a DNA bind-
ing process has at least one DNA as its participant. For
the biological annotation, a suitable term should be
selected from controlled vocabularies, such as cellular
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any medium, provided the original work is properly cited.location for transcription. In addition, for dynamic mod-
els, more information which is usually not described in
experimental data is required. Dimerization and polymer-
ization need different stoichiometry coefficient. Likewise,
there are important issues handled with care and they
cannot be expressed formally in the ontology format.
Based on this viewpoint, we are motivated to establish an
ontology-based instance data validation tool.
Existing tools and inference engines [4-7] detect the
misuse of features and check syntactic validation avail-
able in the ontology semantics. Ontology validation
accomplishes generic ontology evaluation and debugging
based on a schema and definitions for relationships in a
conceptual model, such as logical consistency of the
ontology, cardinality restriction, and subproperty axioms
[8-10] On the other hand, there are some related works
to complement knowledgebase by representing dynamics
of the system, i.e., how to set relevant logical parameters
for Petri net components [11,12], predicting operons
and missing enzymes in metabolic databases [13]. In
such works, the focus is given on representing dynamics
of the system by adjusting initial values and parameters
for components. Another important work is to verify
pathway knowledgebase in terms of event relationships
[14]. Racunas et al. in [14] carried out the verification
on the level of the logical combinations of events, but
without checking the biological meaning of individual
events.
As a complement to such efforts, we had proposed a
validation method to correctly represent biological
semantics and system dynamics for biological path-
ways. [15]. On the basis of the previous work, we
developed a rule-based approach for validating ontol-
ogy-based instance data. As an ontology-based format,
Cell System Ontology (CSO) [16] is used, which can
represent biological pathways for simulation and visua-
lization in OWL (Web Ontology Language) [17]. We
have defined 40 rules embedding biological semantics
to constrain event-specific participants with cardinality,
participant types, cellular location, and others proper-
ties. In particular, 36 biological events are formalized
on the basis of shared knowledge underlying biological
pathways defined in CSO. We believe that our
approach extends the expressiveness of the ontology
and complements biological pathways with necessary
properties, which aims to provide high-quality curated
pathway models.
Methods
We had defined three criteria for validating pathway
models in terms of biological semantics and system
dynamics as follows [15]:
Criterion 1 A structurally correct model to be a bipar-
tite graph with two disjoint sets.
Criterion 2 A biologically correct model to represent
the biological meaning of processes.
Criterion 3 A systematically correct model to capture
generic behaviors that govern the system dynamics.
For the three criteria, a rule-based approach is applied
for validating biological pathways. A rule in this case is
a form of reactive rules, i.e. event-condition-action rules.
When the event happens, the corresponding condition
is evaluated and the action is executed. Some rules are a
form of condition-action rules that directly evaluate the
specified condition with no event. That is, if the condi-
tion is satisfied, then the action is applied. Please note
that the event part in reactive rules is different from
biological events. Each rule specifies a variety of rela-
tionships on the basis of biological events, and consists
of OWL constructors and axioms [17]. The available
constructors and their correspondence with SHOIQ
class expression [18] are summarized in Table 1. Each
letter in SHOIQ indicates S for smallest propositionally
closed description logic with transitive roles, H for role
hierarchy, O for nominals, I for inverse roles, and Q for
qualified number restrictions, respectively.
Relations used in rules are in typewriter type and the
details are as follows: unary relations are classes; binary
relations in all capital letters are properties; and pre-
defined terms (instances) in CSO and variables for
instances are in italics.
Criterion 1: validation for structurally correct models
CSO uses an advanced Petri net named Hybrid Func-
tional Petri net with an extension for the modeling and
simulation of biological pathways [19]. In Petri nets,
three elements, including place, transition, and arc, are
defined. In order to be more intuitive for biological
investigations, the Entity, Process, and Connector classes
are used to denote place, transition, and arc element,
respectively, in CSO. For the details of CSO and its
schema, please refer to [16]. The relationship of the
CSO classes and the Petri net elements is graphically
summarized in Figure 1. The Entity class is used to
represent objects, e.g. mRNA, protein, and small mole-
cules. The Process class is used to represent biological
Table 1 OWL constructors and DL FOL equivalence
Constructor DL syntax FOL syntax
intersectionOf C1 ∩ ... ∩ Cn C1(x) Λ ... Λ Cn(x)
unionOf C1 ∪ ... ∪ Cn C1(x) V ... V Cn(x)
complementOf ¬ C ¬C ( x)
oneOf {a1 ... an} x=a 1 V ... V x=a n
allValuesFrom ∀P.C ∀y.(P(x,y) ® C(y))
someValuesFrom ƎP.C Ǝy.(P(x, y) Λ C(y))
minCardinality ≥ nP.C Ǝ
≥ny.(P(x,y) Λ C(y))
maxCardinality ≤ nP.C Ǝ
≤ny.(P(x,y) Λ C(y))
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tion. The relationship between Entity and Process is
represented by the Connector class, i.e. indicating which
entity is involved in a process.
In the Petri net architecture, an entity reflects the con-
centration of the substance and a process has a speed
that depends on the concentration of the incoming
entity. A connector transfers tokens from the input entity
to the process or from the process to the output entity.
Connector has several Petri nets related properties for
simulation, such as initial value (concentration), mini-
mum value, maximum value, and kinetics. Because of
this reason, Connector is defined as a class in CSO.
There are four types of connectors which imply the role
of the involved entity in the process, including substrate,
inhibitor, activator, and product.
We define that one entity can participate in a process
with only one role. In other words, more than two con-
nectors associated with the same pair of an entity and a
process are not allowed. The valid connections among
Process, Entity, and Connector are five types as shown in
Figure 2. Process can have multiple Connectors and each
connector can have only one Entity by definition in CSO.
To constrain the relation among three classes, we defined
a rule for detecting any invalid connection in the below.
The condition part checks whether there exist more
than two connectors for a given pair of process and
entity. If the condition is true, then perform the action.
This rule requires user intervention to select a correct
connector because it is difficult to decide which connec-
tor is correct without understanding the details of the
interaction [15].
In the rule description, E, C, and A denote Event, Con-
dition, and Action, respectively.
Rule for valid connection
E: Process(x1) Λ Entity(x2)
C:¬[ Ǝ
≤1x3 CONNECTOR(x1,x3) Λ {InputProcessBio-
logical(x3) V InputInhibitorBiological(x3)VI n p u t A s s o -
ciationBiological(x3) V OutputProcessBiological(x3)} Λ
ENTITY(x3,x2)]
A: alert
Criterion 2: validation for biologically correct models
Biological pathways consist of a series of interactions
among entities. As described before, the Process class
represents biological events each of which has character-
istic features such as the type of molecules performing
the event, the number of molecules involved, and the
location which the event occurs. For example, autopho-
sphorylation is a biological event to add a phosphate to
a protein kinase by virtue of its own enzymic activity.
Hence, autophosphorylation is different from phosphor-
ylation because it occurs without any enzyme. Such defi-
nition is usually written in the natural language for the
human users. To facilitate curation procedure, we
defined four types of constraints for biological events
which have specific requirements as follows:
Cardinality constraint A biological event needs con-
straints for the number of participating entities.
Type constraint A biological event needs a specific
type of the entity, such as small molecule and DNA.
Property constraint An entity involved in a biological
event needs to have a specific value for the property
such as protein modification, cellular location, and stoi-
chiometric coefficient.
Property relationship constraint For two entities
involved in the same biological event, there needs a spe-
cific relationship between the values of the same prop-
erty, such that two values should be same.
In this article, we have defined 36 rules for the 36 bio-
logical events. The 36 rules are divided into five groups
depending on the necessary constraints for convenience.
In the following rules, the action part will be different
depending on the constraints in the condition part. Basi-
cally, the action is to show users an error message when
the constraints are not satisfied. We use abbreviations
as follows: hasInput(p1, e1) implies that a process p1 has
an entity e1 which is connected to p1 via one of three
input connectors InputAssociationBiological, InputInhi-
bitorBiological, and InputProcessBiological; hasInputPro-
cess(p1, e1)m e a n st h a te1 is connected to p1 via
InputProcessBiological; and hasOutput(p1, e1) means
that e1 is connected to p1 via OutputProcessBiological.
Figure 1 Relationship between the CSO terms and the Petri net elements. The CSO term is followed by the Petri net element in
parentheses.
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For each e1, w ec a l l e di ta sa ni n p u t ,i n p u t p r o c e s s ,o u t -
put entity, respectively. In addition, for the pre-defined
instances in CSO, the apostrophe prefix is used, such as
‘FT_phosphorylated and ‘ME_Binding. CSO provides
pre-defined common vocabularies to annotate biological
information. It allows to reuse existing structured infor-
mation from other resources and to guide the allowable
values for annotating biological information. Due to lim-
itation of space, we list only several rules here. The for-
mal description and full list of the rules are given in
Additional file 1.
Group 1: rules that need cardinality and type constraints
Biological events in this group are required to have a
specific type of an entity and/or a specific number of
the entity. For example, DNA binding is defined as
binding of a protein to the promoter/enhancer of a
gene. The rule for DNA binding describes that there
needs at least two more inputprocess entities; one of
inputprocess entities has the type as Dna; and the pro-
duct of DNA binding should have the type as Complex.
Both Dna and Complex are subclasses of Entity in the
hierarchy of CSO.
Rule for DNABinding
E: Process(x1) Λ BIOLOGICALEVENT(x1, ‘ME_
DNABinding)
C:¬[ Ǝ
≥2x2,Ǝ
≥1x3 hasInputProcess(x1,x2)s u c ht h a tf o r
one of x2s, Dna(x2) Λ hasOutput(x1,x3) Λ Complex(x3)]
Group 2: rules that need cardinality and
SEQUENCEFEATURE property constraints
This group includes rules for the sequence relevant
interaction such as post-translational modification. In
the rules, hasFeature(x1,‘x2) means that an entity x1 has
a feature type as ‘x2 where ‘x2 is a predefined term for
FeatureType.
Rule for Acetylation
E: Process(x1) Λ BIOLOGICALEVENT(x1, ‘ME_
Acetylation)
C:¬[ Ǝ
=1x2 , Ǝx3, Ǝx4, Ǝx5 hasInputProcess(x1,x2) Λ
hasOutput(x1 ,x3) Λ Entity(x2) Λ Entity(x3) Λ hasFeature
(x3, ‘FT_Acetylated) Λ UNIFICATIONXREF(x2,x4) Λ
UNIFICATIONXREF(x3,x5) Λ sameAs(x4,x5)]
The acetylation event generates a chemically acetylated
protein that has its FEATURETYPE as ‘FT_Acetylated. In
the condition part, the external references for two entities,
i.e, the values of UNIFICATIONXREF (x4 and x5) for the
input x2 and output x3 entities, have to be the same
because x3 is a modified form of x2
Rule for Autophosphorylation
E: Process(x1) Λ BIOLOGICALEVENT(x1,‘ME_
Autophosphorylation)
C:¬[ Ǝ
=1x2,Ǝx3, Ǝx4, Ǝx5, Ǝ
=1x6 hasInputProcess(x1,
x2) Λ hasOutput(x1,x3) Λ Entity(x2) Λ Entity(x3) Λ FEA-
TURETYPE(x3, ‘FT_Phosphorylated) Λ UNIFICA-
TIONXREF(x2,x4) Λ UNIFICATIONXREF(x3,x5) Λ
sameAs(x4,x5) Λ hasInput(x1,x6) Λ Entity(x6)]
Figure 2 Valid connections between Process and Entity via Connector. Legend for icons on the left: blue ovals for Entity, diamond for
Process, and lines between Process and Entity for Connector. Each connection shows the type of the connector: (a) no connection; (b)
InputProcessBiological for substrate; (c) InputInhibitorBiological for inhibitor; (d) InputAssociationBiological for activator; and (e)
OutputProcessBiological for product.
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that the output entity is a phosphorylated form of the
inputprocess entity when no enzyme is present. Two
properties, hasInputProcess(x1,x2)a n dh a s I n p u t ( x1,x6),
imply that x2 and x6 are the same entity. The process
has one output entity whose feature type is defined as
’FT_Phosphorylated.
Group 3: cardinality and STOICHIOMETRY property
constraints
There are three events that indicate the chemical union
of identical molecules. Depending on the definition in
CSO, the stoichiometric coefficient of an inputprocess
entity is 2 for dimerization, more than 2 and less
than 21 for oligomerization, and more than 20 for
polymerization.
In the below, the rule describes that it needs one input-
process entity whose stoichiometry coefficient is equal to
2 and one output entity whose type is Complex.
Rule for Dimerization
E: Process(x1) Λ BIOLOGICALEVENT(x1,‘ME_
Dimerization)
C:¬[ Ǝ
=1x2,Ǝ
=1x3,Ǝ
=1x4 hasInputProcess(x1,x2) Λ
Entity(x2) Λ hasStoichiometry(x2,x3) Λ (x3 =2 )Λ
hasOutput(x1,x4) Λ Complex(x4)]
Group 4: rules that need cardinality and CELLCOMPONENT
property constraints
In some biological events, cellular location of participat-
ing entities is important. For example, the internaliza-
tion and nuclear export events are the movement of the
inputprocess entity from extracellular/plasma membrane
to cytosol, and from nucleoplasm to cytoplasm, respec-
tively, while the translocation event requires that the
inputprocess and output entities just have different cel-
lular locations.
Rule for Internalization
E: Process(x1) Λ BIOLOGICALEVENT(x1, ‘ME_
Internalization)
C:¬[ Ǝ
=1x2, Ǝ
=1x3, Ǝx4, Ǝx5 hasInputProcess (x1,x2) Λ
Entity(x2) Λ CELLCOMPONENT(x2 , ‘CC_Extracellular
or ‘CC_PlasmaMembrane) Λ UNIFICATIONXREF(x2 ,
x4) Λ hasOutput(x1 ,x3) Λ Entity(x3) Λ CELLCOMPO-
NENT(x3, ‘CC_Cytosol) Λ UNIFICATIONXREF(x3,x5) Λ
sameAs(x4,x5)]
It describes that one inputprocess entity should be
located in extracellular or plasma membrane; one out-
put entity should be located in cytosol; both entities x2
and x3 have the same external reference.
Group 5: rules that need cardinality, type, and
CELLCOMPONENT property constraints
This group needs a specific type of an entity located in a
specific cellular location. The transcription event is of
copying information from DNA into new strands of
mRNA. The constraints are that the type of the output
entity is mRNA with cardinality 1; the location of the
output entity is nucleoplasm. The gene expression, ion
transport through ion channel, and translation events
are included in this group.
Rule for Transcription
E: Process(x1) Λ BIOLOGICALEVENT (x1, ‘ME_
Transcription)
C:¬[ Ǝ
=1x2 hasOutput(x1,x2) Λ mRNA(x2) Λ CELL-
COMPONENT(x2, ‘CC_Nucleoplasm)]
Criterion 3: validation for systematically correct models
CSO can represent the dynamics of biological pathways
and is supposed to simulate complex molecular
mechanisms at different levels of details. Once a mathe-
matical model of biological pathways has been gener-
ated, it is necessary to estimate free parameters and
unknown rate constants on the basis of the experimen-
tal data. In this paper, we limit our consideration to
generating a simulatable model to be ready for evalua-
tion and focused on protein turnover.
Normally, proteins are synthesized within the cell and
over time are gradually broken down into individual
amino acids, and this cycle is repeated. To capture this
behavior, we define three rules to recognize the entities
that are synthesized and degraded. For the entity that is
not a product of any process, we add a pre-process that
we assume generates the entity. On the other hand, for
the entity that will be degraded, a degradation process is
added to mimic biological degradation. In the Petri net
formalism, adding a pre-process for such entity makes
the pre-process to be fired without any constraints
when the simulation is started, and the degradation pro-
cess will consume the entity’s concentration. This com-
plementation of the pathway model in CSO will help
users to intuitively understand the given model and the
way in which the model works when using Petri net
based simulation tools such as Cell Illustrator (CI)
[20-22].
In the following rules, the action part improves the
given model by adding new instances (add-instance) and
properties (add-property) .T h ev a r i a b l ei nb r a c e s ,e . g .
<x2>, denotes a new instance. Furthermore, the reverse
properties are used, e.g. ENTITY
–(x1,x4)i se q u a lt o
ENTITY(x4,x1).
Rule for starting entities
C:E n t i t y ( x1) Λ ¬ Complex(x1) Λ ∀x4 {ENTITY
–(x1,x4)
Λ Input(x4)}
A: add-instance Process(<x2>), OutputProcessBiologi-
cal(<x3>)
add-property BIOLOGICALEVENT(<x2>, ‘ME_Un-
knownProduction), CONNECTOR(<x2>, < x3>), ENTITY
(<x3>, x1)
A starting entity is an entity whose type is Entity, but
not Complex which is a subclass of Entity, and is con-
nected to a process only via Input connectors. Hence, if
Jeong et al. BMC Bioinformatics 2011, 12(Suppl 1):S8
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add a unknown production process <x2> and any neces-
sary properties for it. This rule makes the starting entity
be a product of the unknown production process.
Rule for starting complexes
C: Complex(x1) Λ ∀x5 {ENTITY
–(x1,x5) Λ Input(x5)}
A: add-instance Process (<x2>), OutputProcessBiologi-
cal(<x4>)
add-property BIOLOGICALEVENT(<x2>, ‘ME_Bind-
ing), CONNECTOR
– (<x4>, < x2>)
for ∀x3 ENTITY(x1,x3) Λ Entity(x3) do add-property
CONNECTOR
– (x3,<xi>)
add-instance InputProcessBiological(<xi>)
A starting complex is a starting entity whose type is
Complex. For a starting complex, we assume that the
complex is generated via a binding process. In the
action part, a binding process is added and the compo-
nents of the complex will be the participants of the
binding process.
Rule for degrading entities
C: {Protein(x1) V Complex(x1)Vm R N A ( x1) V Small-
Molecule(x1)} Λ ¬{ P r o c e s s ( x2) Λ BIOLOGICALEVENT
(x2 , ‘ME_UnknownDegradation) Λ hasInputProcess(x2 ,
x1)}
A: add-instance Process(<x3>), InputProcessBiological
(<x4>)
add-property BIOLOGICALEVENT(<x3>, ‘ME_
UnknownDegradation), CONNECTOR(<x3>, < x4>)
add-property ENTITY(<x4>,x1)
For Protein, Complex, mRNA, and SmallMolecule, if a
degradation process is not presented, a unknown degra-
dation process is added.
Results
In order to implement the proposed rule-based system,
we used AllegroGraph 3.1 [23] for the CSO data storage
and query engine. AllegroGraph is an RDF (Resource
Description Framework) graph database with support
for SPARQL (SPARQL Protocol and RDF Query Lan-
guage) [24] as a query language. Query manipulation
and CSO data manipulation stored in AllegroGraph are
carried out using Protege OWL API [25] and Jena [26].
This system is applied to macrophage models that are
manually curated and created by using Cell Illustrator
(CI) which is a tool to graphically model and simulate
cellular processes.
Scientific publications reflecting the results of biologi-
cal experiments and including the keywords: Lipopoly-
saccharide (LPS), phorbol 12-myristate 13-acetate
(PMA), macrophage, and signal transduction pathway,
were searched from PubMed [27]. A total of 96 publica-
tions were selected and modeled by curators. One
model was based on a single publication. Basic guide-
lines on how to create and curate models on CI were
provided to the curator. The created model was stored
in Cell System Markup Language (CSML) as a default
format in CI and exported into CSO.
Types of warnings
Our validation method was applied to the 96 macro-
phage models that contained a total of 4910 processes
and 7155 entities. The warnings appeared if the
expected value in the condition part is not correct or
not defined. Table 2 shows the warning description and
its frequency in the first and second columns,
respectively.
The macrophage models did not violate the rule for
structurally correct models in criterion 1. The reason
for this is that the macrophage models were generated
by CI, which supports the drawing of Petri net-based
models via graphic tools and has the ability to check the
connections between processes and entities. Criterion 1
is useful for validating translated data from other data-
bases which have different schemata to CSO like Bio-
PAX2CSO [15,28]. The warnings related to criteria 2
and 3 are given in Table 2.
As described in Methods, the validation rules for cri-
terion 2 generate warnings if a process does not satisfy
its constraints. Among of the four constraints in Meth-
ods, the cardinality constraint is useful to detect other
related problems. If an appropriate entity is not defined,
then the related properties of the entity are not satisfied,
either. For the property constraint, the FEATURETYPE
property is needed for all post-translational modified
Table 2 Description of warnings and their frequencies
Warning description Frequency
Criterion 2: validation of biologically correct models
Cardinality constraint
1. The number of input/inputprocess/output entities is not
correct.
5/18/6
2. The inputprocess/output entities are not defined. 86/2
Type constraint
3. TYPE of entity is wrong/not defined. 179/16
Property constraint
4. CELLCOMPONENT is not correct/not given. 657/4
5. FEATURETYPE is not defined. 1361
6. STOICHIOMETRY is not correct. 61
7. UNIFICATIONXREF is not defined. 1501
Property relationship constraint
8. The values of CELLCOMPONENT that should be different
are the same.
87
Criterion 3: validation of systematically correct models
9. Starting complex that needs to add a binding process. 170
10. Starting entity that needs to add a unknown
production process.
3002
11. Degrading entity that needs to add a unknown
degradation process.
6885
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tors before curation. The value of this property will be
given easily because each rule in group 2 show one-to-
one mapping between two properties, BIOLOGICALE-
VENT and FEATURETYPE. The UNIFICATIONXREF
property is used to uniquely identify biological entities.
It is important not only for ontology instance data vali-
dation, but also for data integration such as model
comparison and model merging. Currently, a biological
entity is identified by external references that give addi-
tional information for the entity. In this work, we use
TRANSPATH [29] as a main reference because it pro-
vides a comprehensive hierarchy for molecules and dis-
tinguishes between different species of the same
molecule and between modified and unmodified forms
of a protein, which is not supported by other databases
Table 3 Biological event and its frequency used in macrophage models and the number of warnings
Biological event Freq. Warnings Reasons (freq.)
1 ME_Autocleavage 2 2 # of input (2)
ME Binding 1898 253 TYPE (169), # of inputprocess (4), no inputprocess (80)
ME_DNABinding 29 0 (0)
ME_DNAReplication 6 0 (0)
ME_Dissociation 37 3 TYPE (3)
ME_GDP-GTPExchange 4 0 (0)
ME_Isomerization 1 0 (0)
ME_MetabolicReaction 40 7 TYPE (7)
ME_ProteasomeDegradation 34 0 (0)
ME_ProteinCleavage 5 0 (0)
ME_UnknownDegradation 45 1 TYPE (1)
2 ME_Acetylation 3 7 (0)
ME ADPRibosylation 2 7 # of input (1)
ME_Amidation 1 1 no output (1)
ME_Glycosylation 1 3 (0)
ME_Nitrosylation 2 6 # of inputprocess (1)
ME Oxidation 12 28 (0)
ME Phosphorylation 448 967 no inputprocess(1), no output (1)
ME_Reduction 1 3 (0)
ME_Sumoylation 2 4 (0)
ME_Ubiquitination 67 166 (0)
ME UnknownActivation 793 1415 # of inputprocess (11), no inputprocess (3)
ME_UnknownInactivation 6 16 (0)
ME_Autophosphorylation 12 36 # of input (2)
ME_Dephosphorylation 9 19 (0)
ME_Deubiquitination 4 11 (0)
3 ME_Dimerization 49 50 STOICHIOMETRY (49),
# of inputprocess (1)
ME_Oligomerization 7 7 STOICHIOMETRY (7)
ME Polymerization 5 5 STOICHIOMETRY (5)
4 ME Internalization 9 22 CELLCOMPONENT (10)
ME_NuclearExport 4 3 CELLCOMPONENT (3)
ME Translocation 136 275 # of output (6), no inputprocess (2)
CELLCOMPONENT (87)
5 ME_GeneExpression 721 262 CELLCOMPONENT (259), TYPE (3)
ME_IonTransportThroughIonChannel 2 4 TYPE (2)
ME Transcription 13 7 CELLCOMPONENT (4), TYPE (3)
ME Translation 364 393 # of input (1), TYPE (7),CELLCOMPONENT(385)
n/a no rules for 8 biological events 136 - -
Total 4910 3983 1121
The biological events are grouped together along with the rules for criteria 2 in Methods. The biological events in the last group have no rules and are notified
with n/a in the first column.
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cially for modified or complex molecules, it takes time
to identify whether the entities have the same basic
molecule. We will improve this procedure to reduce the
search time.
On the other hand, the rules in criterion 3 directly
manipulate the models if the condition part is satisfied.
The rules include the action part to complement a given
model by adding unknown production processes for
starting entities, binding processes for starting com-
plexes, and unknown degradation processes for degrad-
ing entities.
From the results, it is useful to analyze the relation-
ship between biological events and warnings to know
which points demand careful attention. This feedback is
used to give guidelines to curators again.
A total of 44 biological events are used in the 96
macrophage models. Rules are not defined for 8 biologi-
cal events such as cleavage and unknown interaction,
because they have no specific characteristics to distin-
g u i s ht h e mf r o mo t h e r s .S u c he v e n tt e r m so c c u r r e d1 3 6
times, which accounts for 2.8% of the processes in the 96
models. As described in Methods, for criterion 2, the 36
rules are divided into the five groups, each of which has
same or similar constraints. Table 3 shows the frequency
of each biological event occurred in the 96 models, the
number of warnings during validation, and the reasons
for the warnings. The biological events are listed by the
order of rules in the five groups for criterion 2. In the
third column, the warnings are counted on the basis of a
process and its connected entities. The last column
shows the reasons for the warnings per biological event
and frequencies in parentheses, except for warnings
related to FEATURETYPE and UNIFICATIONXREF
properties. For example, ME_ADPRibosylation in group 2
occurred two times in the given models. Among the
seven warnings, only one was related to the number of
input entities.
What is corrected by validation?
We checked each model based on the warnings related
to the cardinality constraint and corrected each model
by reviewing the literature used to generate the model.
Two cases are selected to show how our validation
approach facilitates to correct the macrophage models.
In Figures 3 and 4, A and B indicate the original model
and the corrected model after validation, respectively.
The red boxes in the figures reveal the places in which
the problem happened and the model is changed.
Case 1: Misassignment of the connector type. As shown
in Figure 3, the ME_UnknownActivation event violates the
cardinality constraint of inputprocess entities. This event
term is used in case the mechanism by which leads to the
activation of a molecule is unknown. In the rule for
ME_UnknownActivation, the condition part describes that
only one inputprocess entity is needed to activate. In Fig-
ure 3A, we found that there are two inputprocess entities
and one of those entities plays a role as an enzyme. There-
fore, the type of the connector between the activated Ras
and the process is changed into InputAssociationBiologi-
cal, which represents this event as the activated Ras-
induced Raf1 activation as shown in Figure 3B.
Case 2: Misassignment of the biological event term.
This case shows that one dimerization event also vio-
lates the cardinality constraint of inputprocess entities.
By the rule, ME_Dimerization has only one inputpro-
cess entity whose stoichiometric coefficient is 2.
A ss h o w ni nF i g u r e4 A ,t h eo u t p u te n t i t yi sac o m p l e x
M-CSF(2):M-CSF-1-R(2) generated by the binding of
M-CSF(2):M-CSF-1-R to M-CSF-1-R. We found that
Figure 3 ME UnknownActivation violating cardinality constraint. Legend: A and B represent the original model and the corrected model
after validation, respectively. The biological event causing warnings and the modified parts are in red boxes in the images. The same legend is
used in Figure 4. From the literature, we found that Ras{active} acts as an activator of the process, not as an inputprocess entity. Then, the
connector from Ras{active} to the process is changed to a dashed line with an arrow in B.
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Page 8 of 10the biological event term is assigned mistakenly. Then
the term is changed from ME_Dimerization to
ME_Binding a ss h o w ni nF i g u r e4 B .
Discussion and conclusions
To our knowledge, the validation of ontology-based
instance data for biological pathways has not been
addressed yet. Although the ontology schema is devel-
oped with documentation, the use of the ontology is
usually separated from the development. The generation
of data on the basis of the ontology schema is apt to
contain misuse and misunderstanding of the ontology.
Such errors are not detected by ontology validation car-
ried out on the basis of the ontology schema. The error
correction is usually done manually and is time consum-
ing. As shown in Results, relatively simple rules can
detect the errors in the model, such as misassignment
and misuse of ontology concepts and terms and enhance
the model to be ready for simulation.
Our rule-based validation enables us to provide path-
way models that allow computational tools to explore
t h ep o s s i b l ed y n a m i cb e h a v i o ro fp a t h w a yc o m p o n e n t s
with considering biological meaning. If sophisticated
adjustment of quantitative parameters is needed for
simulation, the correct assignment of biological concepts
and terms are essential for ontology based computa-
tional tools. Therefore, this approach can serve as a pre-
processing step for model integration, exchange and
extraction data, and simulation. In future work, we plan
to develop this system as a plug-in for ontology editors,
and modeling and simulating tools.
Additional material
Additional file 1: The full list of 40 rules.
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